High PKCλ expression is required for ALDH1-positive cancer stem cell function and indicates a poor clinical outcome in late-stage breast cancer patients-Reference-Cited by-同舟云学术

High PKCλ expression is required for ALDH1-positive cancer stem cell function and indicates a poor clinical outcome in late-stage breast cancer patients

Published:2020-07-13 Issue:7 Volume:15 Page:e0235747
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Nozaki Yuka,Motomura Hitomi,Tamori Shoma,Kimura Yumiko,Onaga Chotaro,Kanai Shotaro,Ishihara Yuka,Ozaki Ayaka,Hara Yasushi^ORCID,Harada Yohsuke,Mano Yasunari,Sato Tsugumichi,Sato Keiko,Sasaki Kazunori,Ishiguro Hitoshi,Ohno Shigeo,Akimoto Kazunori^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference77 articles.

1. Molecular portraits of human breast tumours;CM Perou;Nature,2000

2. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications;T Sorlie;Proc Natl Acad Sci U S A,2001

3. A gene-expression signature as a predictor of survival in breast cancer;MJ Van de Vijver;N Engl J Med,2002

4. Genomics in breast cancer-therapeutic implications;PE Lonning;Nat Clin Pract Oncol,2005

5. Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists;S Badve;Mod Pathol,2011

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co‑expression of SLC20A1 and ALDH1A3 is associated with poor prognosis, and SLC20A1 is required for the survival of ALDH1‑positive pancreatic cancer stem cells;Oncology Letters;2024-07-05

2. Luminal B Breast Cancer Coexpressingp62andALDH1A3Is Less Susceptible to Radiotherapy;Anticancer Research;2023-12-30

3. High expression of PKCλ and ALDH1A3 indicates a poor prognosis, and PKCλ is required for the asymmetric cell division of ALDH1A3-positive cancer stem cells in PDAC;Biochemical and Biophysical Research Communications;2023-08

4. Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer;Cancers;2022-11-03

5. High Expression ofCD58andALDH1A3Predicts a Poor Prognosis in Basal-like Breast Cancer;Anticancer Research;2022-10-26